GUPTA, Janesh, Rohan CHODANKAR, Oleg BAEV, Franz BAHLMANN, Eugen BREGA, Anisha GALA, Lars HELLMEYER, Lukáš HRUBAN, Josefine MAIER, Priyanka MEHTA, Amitasrigowri MURTHY, Melanie RITTER, Antonio SAAD, Roman SHMAKOV, Amita SUNEJA, Jozef ZAHUMENSKY a Daniela GDOVINOVA. Synthetic osmotic dilators in the induction of labour-An international multicentre observational study. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY. AMSTERDAM: ELSEVIER SCIENCE BV, 2018, roč. 229, OCT 2018, s. 70-75. ISSN 0301-2115. Dostupné z: https://dx.doi.org/10.1016/j.ejogrb.2018.08.004.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Synthetic osmotic dilators in the induction of labour-An international multicentre observational study
Autoři GUPTA, Janesh (826 Velká Británie a Severní Irsko), Rohan CHODANKAR (826 Velká Británie a Severní Irsko, garant), Oleg BAEV (643 Rusko), Franz BAHLMANN (276 Německo), Eugen BREGA (643 Rusko), Anisha GALA (356 Indie), Lars HELLMEYER (276 Německo), Lukáš HRUBAN (203 Česká republika, domácí), Josefine MAIER (276 Německo), Priyanka MEHTA (356 Indie), Amitasrigowri MURTHY (840 Spojené státy), Melanie RITTER (276 Německo), Antonio SAAD (840 Spojené státy), Roman SHMAKOV (643 Rusko), Amita SUNEJA (356 Indie), Jozef ZAHUMENSKY (703 Slovensko) a Daniela GDOVINOVA (203 Česká republika).
Vydání EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, AMSTERDAM, ELSEVIER SCIENCE BV, 2018, 0301-2115.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30214 Obstetrics and gynaecology
Stát vydavatele Nizozemské království
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 2.024
Kód RIV RIV/00216224:14110/18:00106424
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1016/j.ejogrb.2018.08.004
UT WoS 000447557200011
Klíčová slova anglicky Cervical ripening; Dilapan-S; Induction of labour; Synthetic osmotic dilators; Pregnancy; Birth
Štítky 14110411, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Soňa Böhmová, učo 232884. Změněno: 1. 3. 2019 16:01.
Anotace
Introduction: To evaluate the effects of synthetic osmotic dilators (Dilapan-S/Dilasoft) in women who required induction of labour in a large prospective multicentre international observational study. Materials and methods: Primary outcomes were duration of Dilapan-S/Dilasoft insertion (hours), total induction - delivery interval (hours) and the rate of vaginal deliveries within 24h (%). Secondary outcomes were the number of dilators inserted, Bishop score increase after extraction of Dilapan-S/Dilasoft, complications during induction (uterine contractions, uterine tachysystole and hyperstimulation, effect on the fetus) and post induction (infections and neonatal outcomes), agents / procedures used for subsequent induction of labour, immediate rate of spontaneous labours following cervical ripening period, rate of spontaneous vaginal deliveries, rate of instrumental vaginal deliveries and caesarean sections. RESULTS: Total of 543 women were recruited across 11 study sites, of which, 444 women were eligible for analysis. With Dilapan-S/Dilasoft use of <12 h (n =188) the overall vaginal delivery rate was 76.6% with 45.7% of these births occurring within 24 h, 66% within 36 h and 75.5% within 48 h from insertion of Dilapan-S/Dilasoft. The mean insertion-delivery interval for this group was 24.3(+/- 10.4) hours. With Dilapan-S/Dilasoft use of >12 h (n = 256), the overall vaginal delivery rate was 64.8%, with 16% of these births occurring within 24 h, 48.4% within 36 h and 54.7% within 48 h from insertion of Dilapan-S/Dilasoft. The mean insertion-delivery interval for this group was 39.1(+/- 29.2) hours. The mean gain in the Bishops score was +3.6(+/- 2.3). The mean number of Dilapan-S/Dilasoft dilators used was 3.8 (+/- 1.1). The overall rate of caesarean section was 30.1%. The overall complication rate was low including infection risk. No adverse neonatal outcome was attributable to the use of Dilapan-S/Dilaso Conclusion: Dilapan-S/Dilasoft are safe and effective methods for cervical ripening. Their use is associated with low maternal and neonatal complication rates. Future research should aim at level clinical trials comparing Dilapan-S to other mechanical or pharmacological cervical ripening agents. (C) 2018 Elsevier B.V. All rights reserved.
VytisknoutZobrazeno: 22. 5. 2024 01:40